Welcome to LookChem.com Sign In|Join Free

CAS

  • or

125743-63-7

Post Buying Request

125743-63-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

125743-63-7 Usage

Description

4-(4-METHYLPIPERAZIN-1-YLMETHYL)BENZONITRILE, also known as 4-(4-Methylpiperazinomethyl)benzonitrile (CAS# 125743-63-7), is an off-white solid compound with significant utility in the field of organic synthesis. Its unique chemical structure allows for a wide range of applications across different industries.

Uses

Used in Organic Synthesis:
4-(4-METHYLPIPERAZIN-1-YLMETHYL)BENZONITRILE is used as a synthetic building block for the creation of various organic compounds. Its versatile chemical properties make it a valuable component in the synthesis of pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 4-(4-METHYLPIPERAZIN-1-YLMETHYL)BENZONITRILE is used as an intermediate in the development of new drugs. Its unique structure can be modified to create novel molecules with potential therapeutic applications.
Used in Agrochemical Industry:
4-(4-METHYLPIPERAZIN-1-YLMETHYL)BENZONITRILE is also utilized in the agrochemical industry as a key component in the synthesis of pesticides and other crop protection agents. Its incorporation into these products can enhance their effectiveness and selectivity.
Used in Chemical Research:
In the field of chemical research, 4-(4-METHYLPIPERAZIN-1-YLMETHYL)BENZONITRILE serves as a valuable compound for studying various reaction mechanisms and exploring new synthetic pathways. Its off-white solid form makes it suitable for a wide range of experimental techniques and analyses.
Overall, 4-(4-METHYLPIPERAZIN-1-YLMETHYL)BENZONITRILE is a versatile and essential compound in the realms of organic synthesis, pharmaceutical development, agrochemical production, and chemical research, thanks to its unique chemical properties and diverse applications.

Check Digit Verification of cas no

The CAS Registry Mumber 125743-63-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,5,7,4 and 3 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 125743-63:
(8*1)+(7*2)+(6*5)+(5*7)+(4*4)+(3*3)+(2*6)+(1*3)=127
127 % 10 = 7
So 125743-63-7 is a valid CAS Registry Number.
InChI:InChI=1/C13H17N3/c1-15-6-8-16(9-7-15)11-13-4-2-12(10-14)3-5-13/h2-5H,6-9,11H2,1H3

125743-63-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(4-Methylpiperazinomethyl)benzonitrile

1.2 Other means of identification

Product number -
Other names 4-[(4-methylpiperazin-1-yl)methyl]benzonitrile

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:125743-63-7 SDS

125743-63-7Relevant articles and documents

A novel synthesis of imatinib and its intermediates

Liu, Haiyan,Xia, Wenpin,Luo, Yu,Lu, Wei

, p. 907 - 911 (2010)

A convenient method has been developed for the synthesis of imatinib and two of its intermediates. N-(2-Methyl-5-nitrophenyl)-4-(3-pyridyl)-2-pyrimidin amine, obtained from 2-(methylsulfonyl)-4-(3-pyridyl)pyrimidine via nucleophilic substitution, was reduced by N2H4H2O/FeCl 3·6H2O/C in 92% yield. The resulting amine was condensed with 4-[(4-methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride, which was prepared from 4-(chloromethyl)benzonitrile via substitution and hydrolysis reactions, to provide the final product imatinib in good yield and high purity. Springer-Verlag 2010.

Accessing Aliphatic Amines in C-C Cross-Couplings by Visible Light/Nickel Dual Catalysis

Badir, Shorouk O.,Dong, Weizhe,Molander, Gary A.,Zhang, Xuange

supporting information, p. 4250 - 4255 (2021/06/27)

A general aminoalkylation of aryl halides was developed, overcoming intolerance of free amines in nickel-mediated C-C coupling. This transformation features broad functional group tolerance and high efficiency. Taking advantage of the fast desilylation of α-silylamines upon single-electron transfer (SET) facilitated by carbonate, α-amino radicals are generated regioselectively, which then engage in nickel-mediated C-C coupling. The reaction displays high chemoselectivity for C-C over C-N bond formation. Highly functionalized pharmacophores and peptides are also amenable.

Development of inhibitors against mycobacterium abscessus tRNA (m1G37) Methyltransferase (TrmD) Using Fragment-Based Approaches

Whitehouse, Andrew J.,Thomas, Sherine E.,Brown, Karen P.,Fanourakis, Alexander,Chan, Daniel S.-H.,Libardo, M. Daben J.,Mendes, Vitor,Boshoff, Helena I. M.,Floto, R. Andres,Abell, Chris,Blundell, Tom L.,Coyne, Anthony G.

, p. 7210 - 7232 (2019/08/20)

Mycobacterium abscessus (Mab) is a rapidly growing species of multidrug-resistant nontuberculous mycobacteria that has emerged as a growing threat to individuals with cystic fibrosis and other pre-existing chronic lung diseases. Mab pulmonary infections are difficult, or sometimes impossible, to treat and result in accelerated lung function decline and premature death. There is therefore an urgent need to develop novel antibiotics with improved efficacy. tRNA (m1G37) methyltransferase (TrmD) is a promising target for novel antibiotics. It is essential in Mab and other mycobacteria, improving reading frame maintenance on the ribosome to prevent frameshift errors. In this work, a fragment-based approach was employed with the merging of two fragments bound to the active site, followed by structure-guided elaboration to design potent nanomolar inhibitors against Mab TrmD. Several of these compounds exhibit promising activity against mycobacterial species, including Mycobacterium tuberculosis and Mycobacterium leprae in addition to Mab, supporting the use of TrmD as a target for the development of antimycobacterial compounds.

Cyano-pyrrolo-heteroaryl derivative, preparation method thereof and application of derivative to medicine

-

Paragraph 0254; 0255; 0256; 0257; 0258-0261, (2019/10/23)

The invention relates to a cyano-pyrrolo-heteroaryl derivative, a preparation method thereof and an application of the derivative to medicine, and particularly relates to a novel cyano-pyrrolo-heteroaryl derivative as shown in a general formula (I), a pre

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 125743-63-7